Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 12Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Mantle-Cell 6Leukemia, Lymphocytic, Chronic, B-Cell 6Congenital Abnormalities 6Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Erythroblastic, Acute 5Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma 4Leukemia, Megakaryoblastic, Acute 4Waldenstrom Macroglobulinemia 3Prostatic Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, B-Cell, Marginal Zone 3Burkitt Lymphoma 3Sarcoma 2Pancreatic Neoplasms 2Neoplasms 2Multiple Myeloma 2Melanoma 2Lymphoma, Large-Cell, Immunoblastic 2Breast Neoplasms 2Blast Crisis 2Wilms Tumor 1Tumor Lysis Syndrome 1Thromboembolism 1Thrombocytopenia 1

Interventions

Epoetin Alfa 43Darbepoetin alfa 33epoetin beta 10ferric carboxymaltose 6Cyclosporine 4Cisplatin 4ferrous sulfate 3Radiotherapy 3Lenalidomide 3peginesatide 2luspatercept 2hematide 2fludarabine 2ferric gluconate 2continuous erythropoietin receptor activator 2Therapeutics 2Filgrastim 2Erythropoietin 2Dexamethasone 2Cyclophosphamide 2Brachytherapy 2Antilymphocyte Serum 2ACE-011 2thymoglobulin 1ruxolitinib 1roxadustat 1reolysin 1pegfilgrastim 1obinutuzumab 1leridistim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anemia × alvocidib × Clear all
NCT00735930 2015-04-02

Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
39 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡